Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele

Objective: To determine whether cognitively intact adults with the APOE ε3/ε4 genotype show reduced gray matter density on voxel-based morphometry (VBM) vs those homozygous for the ε3 allele. Methods: Participants were healthy, cognitively intact, right-handed adults, age 19 to 80, who completed genotyping, neuropsychological testing, and MRI. Forty-nine participants had the ε3/ε3 genotype and 27 had the ε3/ε4 genotype. Gray matter data were analyzed using the general linear model as implemented in the Statistical Parametric Mapping package, adjusting for age and sex. Results: The ε3/ε4 participants showed lower gray matter density than the ε3/ε3 participants in right medial temporal and bilateral frontotemporal regions as well as other areas. There were no regions in which ε3/ε4 participants showed higher gray matter density than ε3/ε3 participants. Conclusions: Regionally reduced gray matter density is detectable in cognitively intact adults with a single copy of the APOE ε4 allele.

[1]  Charles D. Smith,et al.  Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. , 1999, Neurology.

[2]  F. Lalonde,et al.  Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women , 2001, Neurology.

[3]  Daniel Bandy,et al.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.

[4]  Cecil R. Reynolds,et al.  A demographically based index of premorbid intelligence for the WAIS—R. , 1984 .

[5]  Richard J. Caselli,et al.  Apolipoprotein E ε4 affects new learning in cognitively normal individuals at risk for Alzheimer’s disease , 2003, Neurobiology of Aging.

[6]  J. Baños,et al.  California Verbal Learning Test-Second Edition , 2002 .

[7]  Emma J. Burton,et al.  A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.

[8]  Richard Mayeux,et al.  Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.

[9]  E. Boerwinkle,et al.  APOE genotype and cognitive decline in a middle-aged cohort , 2005, Neurology.

[10]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[11]  J. Gee,et al.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. , 2003, Brain : a journal of neurology.

[12]  Y. Stern,et al.  APOE related alterations in cerebral activation even at college age , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[14]  Faith M. Gunning-Dixon,et al.  Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study , 2003, Neuropsychologia.

[15]  Carole Dufouil,et al.  No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. , 2005, NeuroImage.

[16]  Charles D. Smith,et al.  Women at risk for AD show increased parietal activation during a fluency task , 2002, Neurology.

[17]  Carole Dufouil,et al.  No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects , 2005, NeuroImage.

[18]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[19]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[20]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[21]  J. M. Guralnik,et al.  The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging , 2003 .

[22]  Karl J. Friston,et al.  Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.

[23]  H. Levin.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1993 .

[24]  G. Small,et al.  Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[25]  Gregory G. Brown,et al.  fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease , 2005, Neurology.

[26]  Karl J. Friston,et al.  Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias , 2002, NeuroImage.

[27]  J. Baron,et al.  Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment , 2002, Neuroreport.

[28]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[29]  A. Saykin,et al.  Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI , 2006, Neurology.

[30]  N C Andreasen,et al.  Image processing for the study of brain structure and function: problems and programs. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[31]  Akira Homma,et al.  Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ϵ4 allele , 1997, Neuroscience Letters.

[32]  O. Selnes.  A Compendium of Neuropsychological Tests , 1991, Neurology.

[33]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[34]  H Yonezawa,et al.  Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. , 1997, Neuroscience letters.

[35]  Naftali Raz,et al.  Age-related differences in the course of cognitive skill acquisition: the role of regional cortical shrinkage and cognitive resources. , 2002, Psychology and aging.

[36]  C. Lustig,et al.  Prefrontal activation patterns in subjects at risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[37]  Andrew J. Saykin,et al.  Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele , 2006 .

[38]  Mark Quigg,et al.  Bipolar deep brain stimulation permits routine EKG, EEG, and polysomnography , 2006, Neurology.

[39]  Ron Dumont,et al.  Delis‐Kaplan Executive Function System , 2008 .

[40]  J. Kastelein,et al.  Apolipoprotein E genotyping on agarose gels. , 1995, Clinical chemistry.

[41]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[42]  G. Frisoni,et al.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry , 2002, Journal of neurology, neurosurgery, and psychiatry.

[43]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[44]  Griselda J. Garrido,et al.  A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease , 2003, Neurobiology of Aging.

[45]  G. Small,et al.  Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease. , 2002, Advanced drug delivery reviews.

[46]  A. Pfeufer,et al.  TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E , 2002, Clinical chemistry and laboratory medicine.

[47]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.